{'fraction_non_alphanumeric': 0.042951541850220265, 'fraction_numerical': 0.01762114537444934, 'mean_word_length': 4.980263157894737, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Secretion of proteohormones and steroids in postmenopause and in women with corporal uterine cancer (author's transl)].


 The hypophyseal, adrenal, and ovarian hormonal production of 5 women, aged an average of 62.8 years, with corporal uterine cancer was determined. 5 healthy women in menopause, aged an average of 58.8 years, were used as a control. Serum samples were used to show the levels of follicle stimulating hormone (FSH) luteinizing hormone (LH), ACTH, estradiol-17beta, and cortisol. At the same time, urine analysis revealed levels of steroids: aggregate estrogens, 17-ketosteroids, and 17-OH steroids. Some differences were found between the levels of cortisol and estradiol-17beta. No differences were found between the levels of FSH, LH, and ACTH. The statistical results lead to the conclusion that a link between corporal uterine cancer is quite possible, but not definitely indicated.
